• DOI:10.1007/s11239-016-1428-2
Corpus ID: 24650202

The use of direct oral anticoagulants in inherited thrombophilia

@article{Skelley2016TheUO,
  title={The use of direct oral anticoagulants in inherited thrombophilia},
  author={Jessica W. Skelley and C. W. White and Angela R. Thomason},
  journal={Journal of Thrombosis and Thrombolysis},
  year={2016},
  volume={43},
  pages={24-30}
}

• Jessica W. Skelley, C. W. White, Angela R. Thomason
• Published 2016
• Medicine
• Journal of Thrombosis and Thrombolysis

To review the use of the direct oral anticoagulant (DOAC) agents in inherited thrombophilia based on the literature. MEDLINE, International Pharmaceutical Abstracts, and Google Scholar searches (1970–May 2016) were conducted for case reports, case series, retrospective cohorts, or clinical trials using the key words: protein C deficiency, protein S deficiency, antithrombin deficiency, activated protein C resistance, Factor V Leiden, hypercoagulable, NOACs, dabigatran, apixaban, rivaroxaban… Expand

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed